CN114573616A - Ternary electrolyte containing bicyclic salt and preparation method and application thereof - Google Patents

Ternary electrolyte containing bicyclic salt and preparation method and application thereof Download PDF

Info

Publication number
CN114573616A
CN114573616A CN202011380868.0A CN202011380868A CN114573616A CN 114573616 A CN114573616 A CN 114573616A CN 202011380868 A CN202011380868 A CN 202011380868A CN 114573616 A CN114573616 A CN 114573616A
Authority
CN
China
Prior art keywords
ring
group
membered
salt
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202011380868.0A
Other languages
Chinese (zh)
Inventor
俞会根
杨萌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing WeLion New Energy Technology Co ltd
Original Assignee
Beijing WeLion New Energy Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing WeLion New Energy Technology Co ltd filed Critical Beijing WeLion New Energy Technology Co ltd
Priority to CN202011380868.0A priority Critical patent/CN114573616A/en
Publication of CN114573616A publication Critical patent/CN114573616A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/052Li-accumulators
    • H01M10/0525Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodes; Lithium-ion batteries
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/056Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes
    • H01M10/0564Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes the electrolyte being constituted of organic materials only
    • H01M10/0566Liquid materials
    • H01M10/0567Liquid materials characterised by the additives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P70/00Climate change mitigation technologies in the production process for final industrial or consumer products
    • Y02P70/50Manufacturing or production processes characterised by the final manufactured product

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Secondary Cells (AREA)

Abstract

The invention relates to a ternary electrolyte containing a bicyclic salt, a preparation method and application thereof, wherein the electrolyte comprises a boron trifluoride salt represented by the following general formula I: in the general formula I, R and R1Represents a ring comprising a monocyclic ring and a polycyclic ring consisting of at least two monocyclic rings; e8Is a chain containing no, at least one atom or a structure containing a ring; m is a metal cation; e4Is a chain without or containing at least one atom; -E3‑OBF3M is connected to E4、E8R or R1On any one atom of; e1、E2、E3Independently a chain structure or a structure containing a ring, which is free of, contains at least one atom; r' and R1' is independently a substituent. Boron trifluoride salts in the present applicationthree-OBF in the structure3M group, and preferably-OBF3M is bonded to the carbon atom C. The boron trifluoride salt can be used as an additive in a battery, and the electrolyte can be applied to a liquid battery, a mixed solid-liquid battery, a semi-solid battery, a gel battery, a quasi-solid battery and an all-solid battery, and has a good effect.
Figure DDA0002809276610000011

Description

Ternary electrolyte containing bicyclic salt and preparation method and application thereof
Technical Field
The invention relates to the technical field of batteries, in particular to a ternary electrolyte containing a bicyclic salt, and a preparation method and application thereof.
Background
The electrolyte is the important and necessary constitution of battery, and the battery has advantages such as high energy density, high voltage, the number of cycles is many, storage time is long, since commercialization, by the wide application in each aspect such as electric automobile, energy storage power station, unmanned aerial vehicle, portable equipment, no matter which kind of direction of application, all urgent needs improve the energy density and the circulation performance of battery under the prerequisite of guaranteeing battery security.
The currently developed liquid battery mainly comprises a positive electrode, a negative electrode, an electrolyte and a diaphragm, and the improvement of the energy density of the battery is to improve the working voltage and the discharge capacity of the battery, namely, a high-voltage high-capacity positive electrode material and a low-voltage high-capacity negative electrode material are matched for use; the improvement of the cycle performance of the battery is mainly to improve the stability of an interface layer formed between an electrolyte and a positive electrode and a negative electrode.
Taking a liquid lithium battery as an example, commonly used cathode materials include high voltage Lithium Cobaltate (LCO), high nickel ternary (NCM811, NCM622, NCM532, and NCA), Lithium Nickel Manganese Oxide (LNMO), lithium rich (Li-rich), and the like; common negative electrode materials include metallic lithium, graphite, silicon carbon, silicon oxycarbide, and the like; the commonly used diaphragm is mainly a polyethylene porous membrane or a polypropylene porous membrane; the liquid electrolyte is a mixture of a non-aqueous solvent and a lithium salt, and is classified into a carbonate liquid electrolyte and an ether liquid electrolyte according to the type of the solvent, and the salt mainly comprises lithium hexafluorophosphate, lithium perchlorate, lithium bis (trifluoromethyl) sulfonimide, lithium difluorooxalate phosphate and the like. The carbonate and ether solvents have narrow electrochemical windows and are easily oxidized and decomposed by high-voltage anode materials, so that the gas generation is serious, the liquid electrolyte is gradually consumed, and the battery rapidly loses efficacy. At present, two solutions are mainly provided, namely, a method for adding a functional additive into a liquid electrolyte and a method for partially or completely replacing the liquid electrolyte with a solid electrolyte.
According to the first method, some functional additives such as fluoroethylene carbonate and vinylene carbonate are added into the liquid electrolyte, a passivation layer is formed on the surface of the electrode in the first-cycle charging and discharging process, the decomposition of the electrode on the liquid electrolyte is inhibited, the discharge specific capacity of the battery is improved, and the cycle life of the battery is prolonged. However, the conventional liquid electrolyte additive does not contain dissociable ions, and only ions of the positive electrode can be consumed to form a surface passivation layer which only conducts ions and does not conduct ions, and if the formed passivation layer is unstable, the passivation layer is continuously destroyed and formed along with the increase of the cycle number, so that active lithium ions in the battery are continuously consumed, the first-cycle discharge capacity of the battery is low, the capacity attenuation is serious, and the battery still loses efficacy quickly. If the functional groups are combined with the groups capable of providing ions, the added salt/additive can form a passivation layer which conducts ions and has good stability on the surface of the electrode, and the liquid electrolyte with a narrow electrochemical window can be applied to a high-voltage battery system due to less consumption of ions from the positive electrode.
For method two, the liquid electrolyte is partially or fully replaced with a solid electrolyte. The solid electrolyte mainly comprises a polymer electrolyte, an inorganic oxide electrolyte and a sulfide electrolyte. The sulfide electrolyte is extremely sensitive to air and is easy to generate hydrogen sulfide, the electrochemical window is narrow, and the sulfide electrolyte is unstable to the anode material of an oxide; the oxide electrolyte has too high hardness and high brittleness; the electrochemical window of the polymer electrolyte is not wide, the conductivity is low, and the ion transference number is low. Therefore, the currently used electrolyte is still mostly a liquid electrolyte or a semi-solid electrolyte, and the secondary battery is mostly a liquid battery or a semi-solid battery. Sodium ion batteries also suffer from similar problems. It is also very important to develop single ion conductor polymer electrolyte with higher conductivity, wide electrochemical window and high ion migration number.
One of the groups of the Applicant has been working on compositions containing-OBF obtained by substitution of a hydroxyl group-OH3Compounds of the M group were studied. Due to [ -OBF [ ]3]-Is a strongly polar group capable of forming a salt structure with a cation, thus, -OBF3M has a strong sense of presence in one molecular structure, which may change the properties of the entire molecular structure. In the prior art, BF-containing samples were also only investigated by very individual researchers3Combination of radicalsThe substances were studied sporadically and all contained only one BF3The group is researched, at present, no great results are obtained, and no results of industrial application are found; the prior art is directed to-O-BF3Investigation of the M group, let alone three-OBF3Studies of the M group are published. This is also because-OBF3M is strongly present, if-OBF is added to the molecule3The number of M may vary unpredictably in the overall properties of the overall molecular structure, and thus research teams may be able to conduct procedures involving two or more-OBFs3M research, resistance is greatly increased, time cost and economic cost are extremely high, and results are not well predicted, so that the research team only always contains one-OBF3M was studied. Even if the pair contains one-OBF3M is used for research, and the prior art is very few, so that the reference value is very small, and the research on three groups has no reference source. The group also discovered unexpectedly in occasional studies-OBF containing trihydroxy substitutions3The M organic matter has a good effect of improving the cycle performance of the battery, so that a special research team is organized to research the application of the ternary structure in the liquid battery or the solid battery, and a good research result is obtained.
More importantly, the present application is directed to-OBF3M Structure attached to the link rings, i.e. three-OBF3M is either directly or indirectly attached to a ring, and the two rings are connected by a single bond, a chain, or a cyclic group. This is because such structures are particularly and the electrical and other chemical properties of the ring itself are also more specific and self-contained, three-OBF3M, when attached to a ring, affects the chemical and physical properties of the entire ring, where it is substantially different from a single ring, chain structure, etc., and therefore the relationship or deductibility between them is uncertain. Thus, connecting-OBF to the link3M, it is possible to produce effects different from those of other structures, in particular the connection of three-OBFs3M, it may have a more unexpected superior effect. Therefore, the subject of this application is identified as having the direct or indirect attachment of-O-BF to the linking ring3M, i.e.The main body of the ring is distinguished from aromatic ring, heterocyclic ring, carbocycle and unsaturated ring, and the like to carry out independent research, so that the-O-BF can be more specifically and definitely determined3M is the specific case when linking rings.
Disclosure of Invention
The invention provides a ternary electrolyte containing a bicyclic salt, and preparation and application thereof, aiming at overcoming the defects in the prior art.
The purpose of the invention is realized by the following technical scheme:
one aspect of the present invention is to provide a ternary electrolyte containing a bicyclic salt, which is characterized in that: the electrolyte comprises a bicycloheteroboron trifluoride salt represented by the following general formula I:
Figure BDA0002809276590000021
in the above general formula I, R and R1Represents a ring comprising a monocyclic ring and a polycyclic ring consisting of at least two monocyclic rings; e8Is a chain of no, at least one atom or a structure containing a ring, E8When cyclic, it also includes monocyclic or polycyclic rings; when E is8When not present, R and R1By single or double bond (e.g. R-R)1Or R ═ R1) (ii) a M is a metal cation; e4Is a chain without or containing at least one atom; in the general formula I there is also one-E3-OBF3M, the-E3-OBF3M is connected to E4、E8R or R1On any one atom of; e1、E2、E3Independently a chain structure or a structure containing a ring, which is free of, contains at least one atom; r' and R1' is independently a substituent, any one H on the representative ring may be substituted by a substituent, and the substituent may be substituted for one H or two or more H, and if two or more H are substituted, the substituents may be the same or different, i.e., each H may be substituted by a substituent defined as any one of R.
Further, in the tubeIn the formula I, E8The linkage to R and R1 is by a single or double bond, rather than a common/atomic connection as bridged spirocyclic rings and the like.
Further, the monocyclic ring is a three-to twenty-membered ring, and the monocyclic ring includes a saturated carbocyclic ring, a saturated heterocyclic ring, an unsaturated carbocyclic ring and an unsaturated heterocyclic ring; saturated, unsaturated heterocycles are rings containing at least one heteroatom selected from O, N, P, Si, Se, B, S, Se or Al.
Further, the polycyclic ring composed of a single ring includes a parallel ring, a bridged ring, a spiro ring, a ring containing at least two of the aforementioned three polycyclic rings at the same time; the ring combination is formed by combining more than 2 monocyclic rings together, and in the two combined rings, two adjacent atoms on one ring share with two adjacent atoms on the other ring; the bridge ring is a polycyclic structure sharing more than two atoms; the spiro ring shares one atom with two adjacent monocyclic rings.
Further, in the formula I, with-OBF3The atoms to which M is directly connected include C, S, N, Si, P, B or O; preferably with said-OBF3The atom to which M is attached is a carbon atom C, and it may be preferred that at least one of the carbon atoms is attached to a carbon atom other than a carbonyl carbon, including-C ═ O or-C ═ S.
Further, H on any one C in the general formula I can be independently substituted by halogen, that is, H on any C in I such as a ring, a substituent, E, etc., can be substituted, and therefore, in the following definition, some technical features do not particularly describe the case where H on any one C is substituted by halogen.
Further, the substituents R' and R1' independently include H, halogen atoms, ether oxygen bonds/groups, ether sulfur bonds/groups, nitro groups, cyano groups, C ═ O containing substituents, O ═ S ═ O containing substituents, N containing substituents, alkyl groups, heteroalkyl groups, alkenyl groups, heteroalkenyl groups, alkynyl groups, heteroalkynyl groups, alkenylalkynyl groups, heteroalkynyls, ═ O, ═ S, and,
Figure BDA0002809276590000031
A salt substituent, a cyclic substituent, and a group in which H on any one of C of these groups is substituted with a halogen atom.
Preferably, the cyclic substituent includes a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring and a polycyclic substituent having two or more ring structures at the same time; r5、R6Independently H, alkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, and heteroalkynyl; such salt substituents include, but are not limited to, sulfate (e.g., lithium sulfate, sodium sulfate, potassium sulfate), sulfonate (e.g., lithium sulfonate), sulfonimide salt (e.g., lithium sulfonimide), carbonate, carboxylate (e.g., COOLi), ether salt (e.g., -OLi, -SLi), nitrogen salt (e.g., COOLi), and the like
Figure BDA0002809276590000036
=N-Na+Etc.), silicates, phosphates, hydrochlorides, nitrates, azides; any of the structures in the heteroalkane/alkene/alkyne/alkenynyl group contains at least one non-carbon atom selected from halogen, S, N, O, P, Se, Ca, Al, B, or Si.
Each of the above substituents being capable of optionally being bonded to a first substituent on an atom, which first substituent may be bonded to substituent R' or R1The species defined are consistent.
Further, E1、E2Or E3Independently selected from the group consisting of alkyl, cycloalkyl, heterocycloalkyl, alkenyl, heteroalkenyl, a group containing a cyclic structure, a substituted or unsubstituted alkyl, cycloalkyl, heterocycloalkyl, or a substituted or unsubstituted alkyl, heterocycloalkyl, or substituted cycloalkyl group,
Figure BDA0002809276590000033
Or ═ N-R7’-。E4Is of a chain structure without or with 3 free connecting bonds, and the 3 free connecting bonds are respectively connected with the ring R, E1And E3Is connected, if E1And/or E2If not, then E4Free connecting key of and-OBF3And M is connected. E8Is nothing, ether oxygen group, ether sulfur group, carbonyl group, ester group, phosphate group, alkyl group, heteroalkyl group, alkenyl group, heteroalkenyl group or cyclic group, and the cyclic group comprises
Figure BDA0002809276590000034
and-R52-R51-R53-,R51Is a first monocyclic ring, a first fused ring or a first linked ring, wherein the first linked ring contains at least two monocyclic rings, adjacent monocyclic rings are linked by a single bond or by a chain containing at least one atom, R is52And R53Independently a chain containing no or at least one atom;
Figure BDA0002809276590000035
represents a second monocyclic ring or a second fused ring, R50Represents an atom in a second monocyclic ring or a second fused ring, the atom containing two atoms which are respectively associated with R and R1A linked key. Wherein the double bond in the heteroalkenyl group includes a structure containing a carbon-carbon double bond C ═ C and a structure containing a carbon-nitrogen double bond C ═ N, and R is5’、R6' and R7' independently of R in the preceding paragraph5、R6The species defined in (1) are identical.
E8Optionally attached to a second substituent, which may be substituted with substituent R' or R1The species defined are consistent.
Further, the monocyclic ring includes a saturated carbocyclic ring, a saturated heterocyclic ring, an unsaturated carbocyclic ring and an unsaturated heterocyclic ring, and the monocyclic ring is a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a nine-membered ring, a ten-membered ring, a twelve-membered ring, a fourteen-membered ring, a sixteen-membered ring or an eighteen-membered ring. Wherein the tri-unsaturated carbocyclic ring comprises a1 double-bonded carbocyclic ring; a ternary saturated heterocycle includes a saturated ring containing 1 or 2 heteroatoms; the ternary unsaturated heterocycle comprises 1 double bond and simultaneously contains 1 or 2 heteroatoms; the quaternary unsaturated carbocycle includes carbocycles containing 1 double bond or 2 double bonds, and if 2 double bonds, they are not adjacently disposed; a quaternary saturated heterocycle includes a saturated ring containing 1 or 2 heteroatoms; the quaternary unsaturated heterocycle is a four-membered ring which contains 1 or 2 double bonds and simultaneously contains 1 or 2 heteroatoms; five-membered unsaturated carbocycles include carbocycles containing 1 double bond or 2 double bonds, and if 2 double bonds, they are not disposed adjacently; a five-membered saturated heterocycle includes a saturated ring containing 1,2, 3, or 4 heteroatoms; the five-membered unsaturated heterocyclic ring containing 1 or 2 bisA bond and contains simultaneously 1,2, 3 or 4 heteroatoms; the six-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2 or 3 double bonds, and if 2 or 3 double bonds are contained, the two carbocyclic rings are arranged non-adjacently; six membered saturated heterocyclic rings include saturated rings containing 1,2, 3 or 4 heteroatoms; the six-membered unsaturated heterocycle is a six-membered ring which contains 1,2 or 3 double bonds and simultaneously contains 1,2, 3, 4, 5 or 6 heteroatoms; the seven-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2 or 3 double bonds, and if 2 or 3 double bonds are contained, the two carbocyclic rings are arranged non-adjacently; a seven membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3 or 4 heteroatoms; the seven-membered unsaturated heterocycle is a seven-membered ring which contains 1,2 or 3 double bonds and simultaneously contains 1,2, 3 or 4 heteroatoms; the eight-membered unsaturated carbocyclic ring includes carbocyclic rings containing 1,2, 3 or 4 double bonds, and if 2 or more double bonds are present, they are not adjacent to each other; an eight membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3 or 4 heteroatoms; an eight-membered unsaturated heterocycle is an eight-membered ring containing 1,2, 3 or 4 double bonds and simultaneously 1,2, 3 or 4 heteroatoms; the nine-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2, 3 or 4 double bonds, and if 2 or more double bonds are present, the two double bonds are not adjacent to each other; a nine membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3 or 4 heteroatoms; the nine-membered unsaturated heterocycle is a nine-membered ring which contains 1,2, 3 or 4 double bonds and simultaneously contains 1,2, 3 or 4 heteroatoms; the ten-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2, 3 or 4 double bonds, and if 2 or more double bonds are present, the two are arranged non-adjacently; a ten-membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3, or 4 heteroatoms; the ten-membered unsaturated heterocycle is a ten-membered ring containing 1,2, 3 or 4 double bonds and simultaneously containing 1,2, 3 or 4 heteroatoms; the twelve-membered ring, the fourteen-membered ring, the sixteen-membered ring and the eighteen-membered ring respectively and independently comprise a saturated carbon ring, a saturated heterocyclic ring containing 1,2, 3, 4, 5 or 6 heteroatoms and an unsaturated heterocyclic ring containing 1,2, 3, 4, 5 or 6 heteroatomsAnd rings containing 1,2, 3, 4, 5 or 6 unsaturated bonds. The polycyclic ring is formed by combining more than 2-5 single rings; any one of the monocyclic ring or polycyclic ring is connected with the substituent R' or R1'. Any one heteroatom of the heterocyclic ring is independently selected from O, N, P, Si or S.
Further, the monocyclic ring is selected from the following rings: cyclopropane, cyclopropene, ethylene oxide, cyclobutane,
Figure BDA0002809276590000041
Cyclobutene, cyclopentane, cyclopentene (containing one double bond), cyclopentadiene, pyrrole, dihydropyrrole
Figure BDA0002809276590000042
Tetrahydropyrrole, furan, dihydrofuran
Figure BDA0002809276590000043
Tetrahydrofuran, thiophene, dihydrothiophene
Figure BDA0002809276590000044
Tetrahydrothiophene, imidazole, pyrazole, thiazole
Figure BDA0002809276590000045
Dihydrothiazoles and oxazoles
Figure BDA0002809276590000046
Dihydrooxazole and isoxazole
Figure BDA0002809276590000047
Dihydroisoxazole, triazole
Figure BDA0002809276590000048
Dihydrotriazoles, tetrazoles, benzene rings, pyridines, dihydropyridines, tetrahydropyridines, pyrimidines, pyrazines, pyridazines, p-diazabenzenes, triazines
Figure BDA0002809276590000049
Cyclohexane, bisOxanes of the formula
Figure BDA00028092765900000410
Cyclohexene (containing a double bond), 1, 3-cyclohexadiene, 1, 4-cyclohexadiene, piperidine, pyran, dihydropyran, tetrahydropyran, dihydrothiopyran
Figure BDA00028092765900000411
Tetrahydrothiopyrans, dithianes
Figure BDA0002809276590000051
Figure BDA0002809276590000051
1, 2-dithianes
Figure BDA0002809276590000052
[1,3]Oxazolidines
Figure BDA0002809276590000053
Morpholine, piperazine, pyrone, dihydropyrimidine, tetrahydropyrimidine, hexahydropyrimidine, cycloheptane, cyclohexene oxide, cycloheptene, 1, 3-cycloheptene, 1,3, 5-cycloheptene, cyclooctane, cyclononane triene, cyclododecane, 1,5, 9-triazacyclododecane, dihydropyrimidine, tetrahydropyrimidine, hexahydropyrimidine, cycloheptane, epoxyhexane, cycloheptene, 1, 3-cycloheptene, cyclooctane, cyclononane, cyclododecane, 1,5, 9-triazacyclododecane, dihydropyrimidine, tetrahydropyrimidine, hexahydropyrimidine, cycloheptane, cyclododecane, and mixtures thereof,
Figure BDA0002809276590000054
Figure BDA0002809276590000055
Figure BDA0002809276590000056
Or 18-crown-6; the polycyclic ring is composed of the above-mentioned monocyclic ring.
Further, the general formula I includes, but is not limited to, the following compounds:
Figure BDA0002809276590000057
Figure BDA0002809276590000058
Figure BDA0002809276590000061
in the above structure, Q1、Q2、Q3All indicate-OBF3M; e in each ring structure1、E2、E3Independently in accordance with any of the above definitions; e in each ring structure8Are each independently of E as defined in any of the preceding paragraphs8The consistency is achieved; any one H on each ring can be independently selected from A1、A2、A3Or A4Any one substituent of (A), A1、A2、A3Or A4Are all independently selected from the substituents R' or R as described in any of the above paragraphs1' any one substituent defined in (1).
Further, the substituents R', R1’、A1、A2、A3Or A4Independently selected from H, halogen atom, carbonyl, ester group, aldehyde group, ether oxygen group, ether sulfur group, ═ O, ═ S,
Figure BDA0002809276590000071
Nitro, cyano, amino, amide, sulfonamide, sulfoalkane, hydrazino, diazo, alkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, alkenylalkynyl, heteroalkynyl, cyclic substituents and substituents of said salts; ester groups include, among others, carbonates, carboxylates, sulfonates, and phosphates.
Preferably, in the substituent, the halogen atom comprises F, Cl, Br, I, and the carbonyl group is-R10COR11The ester group is-R12COOR13、-R12OCOR17、-R12SO3R13、R12O-CO-OR13Or
Figure BDA0002809276590000072
The ether oxygen radical is-R14OR15The etherthio radical is-R14SR15Amino is ═ N-R20
Figure BDA0002809276590000073
or-CH ═ N-R24Amide is
Figure BDA0002809276590000074
Figure BDA0002809276590000075
Sulfonamide group of
Figure BDA0002809276590000076
The sulfoalkane is-R18SO2R19The diazo group is-N ═ N-R38Salt substituents include, but are not limited to, sulfate, sulfonate, sulfonimide, carbonate, carboxylate, nitrate; wherein R is5、R6、R10、R11、R12、R13、R14、R15、R16、R17、R18、R19、R20、R21、R22、R23、R24、R25、R26、R27、R28、R29、R30、R31、R32、R33、R34、R35、R38Independently is C1-10Alkyl radical, C1-10Heteroalkyl group, C1-10Alkenyl radical, C1-10Heteroalkenyl radical, C1-10Alkynyl, C1-10Heteroalkynyl, heteroalkenyl/alkynyl being a heteroalkenyl/alkenyl/alkynyl group bearing at least one of the non-carbon atoms; the group directly attached to N or O can also be a metal ion, such as R13、R15、R16、R20、R22、R24、R26、R30、R31、R35Etc. R5、R6、R10、R12、R14、R18、R20、R21、R22、R23、R24、R25、R26、R27、R29、R30、R33、R35、R38Can independently be H or。
Further, R5、R6、R10、R11、R12、R13、R14、R15、R16、R17、R18、R19、R20、R21、R22、R23、R24、R25、R26、R27、R28、R29、R30、R31、R32、R33、R34、R35Independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, trifluoromethyl, hexyl, heptyl, or alkenyl; r38Is phenyl or phenyl with methyl, halogen atom or nitro connected; wherein R is5、R6、R10、R12、R14、R18、R20、R21、R22、R23、R24、R25、R26、R27、R29、R30、R33、R35、R38May independently be H or none; the group directly attached to N or O can also be a metal ion, such as R13、R15、R16、R20、R22、R24、R26、R30、R31、R35Etc., the ester group can also be selected from-OCH2COOEt、COOCH2COOEt、COOCH2OCOCH(CH3)3、CH=CHCOOCH2CH3or-CH2(CH2)6COOEt; the amide can also be selected from
Figure BDA0002809276590000077
R18Can also be-O-; r20Can also be NO2、CH2COOCH3Cyclopentane, cyclohexane, cyclohexadiene or phenyl, the amino group can also be
Figure BDA0002809276590000078
Cyano radicals selected from-CN, -CH2CN、-SCH2CH2CN、-N(CH3)CH2CH2CN or-CH2CH2CN。
The alkyl group includes methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, or octadecyl; heteroalkyl is an alkyl group containing at least one of the heteroatoms; preferably, the heteroalkyl group comprises-CH2CH2-O-NO2、-CH2S-S-CH3、-CO-CH2-Cl、-CO-CH2-Br、-CH2NO2、-Z1CF3、-CH(CH3)2、-CH2Z1、-CH2Z1CH3、-CH2CH2Z1、-Z1(CH2CH3)2、-CH2N(CH3)2、-CH2Z1CH(CH3)2、-C(CH3)2CH2C(CH3)3、-C(CH3)2CH2CH3、-COCH2CH(CH3)2、-CH(Z1CH2CH3)2、-CH2CH(SCH2CH3)2、-CH2Z1CH(CH3)2、-OCH2(CH2)6CH3、-CH2(CH3)Z1CH3、-CH2(CH3)Z1CH2CH3、-CH2CH2Z1CH3、-CH2CH(CH3)Z1CH3-、-CH(CH3)CH2Z1CH3、-CH2CH2Z1CH2CH3、-CH2CH(CH3)Z1CH2CH3、-CH(CH3)CH2Z1CH2CH3、-CH2CH2CH2Z1CH3、-CH2CH2CH2Z1CH2CH3、-CH2CH(CH3)CH2Z1CH3、-CH2CH2CH(CH3)Z1CH3、-Z1CH2CH2Si(CH3)3
Figure BDA0002809276590000081
Figure BDA0002809276590000082
The alkenyl group includes vinyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, 1, 3-hexadienyl, -C (CH)3)=CH2、-CH2CH=CH(CH3)2、-CH2CH=C(CH3)CH2CH2CH=C(CH3)2、-C(CH3)=CH2、-CH2CH=CH-CH2CH3
Figure BDA0002809276590000083
Figure BDA0002809276590000084
And the like belong to the alkenyl category; heteroalkenyl is alkenyl containing at least one of the heteroatoms; preferably, the heteroalkenyl group comprises-N ═ CHCH3、-CH2CH=CH-(CH2)3COOCH3、-OCH2CH=CH2、-CH2-CH=CH-Z1CH3、-CH2CH=CH-(CH2)3COOCH(CH3)2、-CH2-CH=CH-Z1CH3、-C(CH3)=CHCH3、-CH2CH=C(CH3)2、-C(CH3)=CHCOCH3、-COCH=CHCH2CH3、-C(CH3)=CH2、-CH2CH2CO-(CH2)6-CH3、-CH=CHCH2-CH2Z1CH3
Figure BDA0002809276590000086
The alkynyl group comprises ethynyl, propynyl, butynyl, pentynyl, hexynyl or heptynyl; heteroalkynyl is an alkynyl group containing at least one of the heteroatoms; preferably said heteroalkynyl radical comprises-C ≡ CCH2CH2CH2Z1CH2CH3、-C≡CCH2Z1CH2CH3or-C.ident.C-Si (CH)3)3(ii) a The alkenylalkynyl group is a structure containing at least one double bond and at least one triple bond; preferably, said alkenynyl is selected from: -C ≡ CCH ═ CHCH3or-C ≡ CCH2CH2CH=CHCH3(ii) a Said heteroalkynyl is an alkynyl containing at least one of said heteroatoms; preferably, said heteroalkynyls are selected from: -CH ═ c (cn)2、-C≡CCH2CH=CHCH2Z1CH3
The cyclic substituents include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and polycyclic rings, preferably selected from the group consisting of cyclopropylalkyl, cyclopropene, oxirane, cyclobutylalkyl, cyclobutylheteroalkyl (e.g., cyclobutylheteroalkyl)
Figure BDA0002809276590000087
Figure BDA0002809276590000088
Etc.), cyclobutenyl, cyclobutynyl, phenyl, pyridine, pyrimidine, cyclopentyl, cyclopentenyl, cyclopentadienyl, pyrrolyl, dihydropyrrolyl, tetrahydropyrrolyl, furyl, dihydrofuran, tetrahydrofuran, thiophene, dihydrothiophene, tetrahydrothiophene, imidazolyl, thiazolyl, dihydrothiazolyl, isothiazolyl, dihydroisothiazolyl, pyrazolyl, oxazolyl, and the like
Figure BDA0002809276590000089
Dihydrooxazolyl, tetrahydrooxazolyl, isoxazolyl, dihydroisoxazolyl, thiopyran, dihydrothiopyran
Figure BDA00028092765900000810
Tetrahydrothiopyrans, dithianes
Figure BDA00028092765900000811
Figure BDA00028092765900000811
1, 2-dithianes
Figure BDA00028092765900000812
Figure BDA00028092765900000812
1, 4-dithiane, [1,3 ]]Oxazolidines
Figure BDA00028092765900000813
Dioxane (dioxane)
Figure BDA00028092765900000814
1, 3-dioxolane, triazolyl, cyclohexane, cyclohexenyl, cyclohexadiene, piperidine, pyran, dihydropyran, tetrahydropyran, morpholine, piperazine, pyrone, pyridazine, pyrazine, triazine, dihydropyridine, tetrahydropyridine, dihydropyrimidine, tetrahydropyrimidine, hexahydropyrimidine, biphenyl, naphthyl, anthryl, phenanthryl, quinonyl, carbazolyl, indolyl, isoindolyl, quinolyl, purinyl, alkanyl, benzoxazole, p-diazepine, pyrenyl, acenaphthenyl, phenanthrenyl, and phenanthrenyl,
Figure BDA00028092765900000815
Figure BDA0002809276590000091
Wherein, Z1is-O-, -S-S,
Figure BDA0002809276590000092
-COO-、-N=N-、
Figure BDA0002809276590000094
R36、R37、R38、R43、R90、R91、R92Independently selected from H, methyl, ethyl, propyl, isopropyl, butyl, fluoromethyl, fluoroethyl, methoxy, ethenyl, propenyl, or a metal ion; r mentioned above or below36、R37Consistent with the definition herein, it is not repeated.
Any one ring of the ring substituents is independently linked to the substituted bicyclic ring through any one of the following linking groups: -CH2-、-CH2CH2-、-CH2CH2CH2-、-CH(CH3) -, butyl, ethylene, propylene, butene, acetylene, propyne, -COO-, -CO-, -SO2-、-N=N-、-O-、-OCH2-、-OCH2CH2-、-CH2OCH2-、-COCH2-、-CH2OCH2CH2-、-OCH2CH2O-、-COOCH2CH2-、-S-、-S-S-、-CH2OOC-、-CH=CH-CO-、-COOCH2OCOCH2-、
Figure BDA0002809276590000095
Or a single bond, i.e. a direct ring-to-ring connection; r42Selected from H, methyl, ethyl or propyl; r83Selected from alkyl or cyclic.
R20Independently selected from said linking groups, preferably R20Is none (i.e. singly bonded), -CH2-or-CO-, R21Is H, hydrocarbyl, heterohydrocarbyl or cyclic;
Figure BDA0002809276590000096
and
Figure BDA0002809276590000097
independently a monocyclic ring or a polycyclic ring consisting of at least two monocyclic rings, preferably, the monocyclic ring can be a 3-8 membered ring, which can be a saturated carbocyclic ring, a saturated heterocyclic ring, an unsaturated carbocyclic ring and an unsaturated heterocyclic ring, and the polycyclic ring can be a fused ring, a bridged ring or a spiro ringAnd, more preferably,
Figure BDA0002809276590000098
and
Figure BDA0002809276590000099
independently phenyl, cyclopropyl, oxirane, cyclobutyl, cyclopentyl, cyclopentenyl, furan, dihydro/tetrahydrofuran, thiophene, dihydro/tetrahydrothiophene, pyrrole, dihydro/tetrahydrothiophene, thiazole, isothiazole, oxazole, isoxazole, pyridine, pyrimidine, piperidine, 1, 3-dioxacycloalkane, imidazole, pyrazine, pyridazine, p-diazabenzene, triazine, cyclohexane, cyclohexenyl, cycloheptyl.
Any atom with H on any ring of the above ring substituents can be selectively connected with the first substituent; the first substituent is selected from H, halogen atom, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, fluoromethyl, fluoroethyl, methoxy, ethoxy, nitro, alkenyl, alkynyl, ester group, sulfonate, sulfoalkane, amido, cyano, aldehyde group, -SCH3、-COOCH3、COOCH2CH3、-OCF3、=O、=S、-N(CH3)2、-CON(CH3)2、-SO2CH3、-SO2CH2CH3Or a substituent wherein H on any one C of these groups is substituted with a halogen.
Further, E1、E2Or E3Independently selected from the group consisting of none, carbonyl, keto, ester, -CH2-、-CH2CO-, ethyl, N-propyl, isopropyl, N-butyl, isobutyl, N-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, ethenyl, propenyl, butenyl, pentenyl, hexenyl, octenyl, nonenyl, decenyl, ethynyl, propynyl, butynyl, cyclohexyl, cyclopentyl, 1, 3-hexadienyl, -C ═ N-, -C (CH)3)2-、-CH(CH3)-、-CH(CF3)-、-C(CF3)2-、-CH2CH2CH(CH3)-、-Z'1CH2CH2-、-CH=CH-CO-、-OCH2CH2CH2CO-、=N-CH2-CO-、-Z'1CH2CO-、-Z'1CH2CH2CO-、-Z'1CH2CH2CH2CO-、-COOCH2CH2-、-O-CH2(CH2)4CH2-、-CH2CH2CO-、-CH2CH(CH3)-、-OCH2-、-CH(CH3)CO-、-CH(CH2Cl)-、-CH(OCH3)-、-CH(CHO)-、-CH2COCO-、-C(CH3)2CH2CH2-、-CH2(CH2)5CO-、-CH2(CH2)6CO-、-N=C(CH3)-、-O-(CH2)6-、-CH2Z'1CH2-、-CH2(CH3)Z'1CH2-、-CH2CH2Z'1CH2-、
Figure BDA0002809276590000101
-O-CH2-CH2-O-CH2-CH2-、
Figure BDA0002809276590000102
Figure BDA0002809276590000103
Figure BDA0002809276590000104
-(CH3)CHCH2CH2Z’1CH2-、-O-CH(CH3)-(CH2)4CH2-、
Figure BDA0002809276590000105
Figure BDA0002809276590000106
E8Is selected from-CH, -CH2-、-CH2CH2-、-C(CH3)2-、-CH(CH3)-、-CH(CH3)CH(CH3)-、-CH(Et)CH(Et)-、=CH-CH=、-CH2CH(CH3)-、-CO-、-O-、COO-、-OCH2O-、-CH=CH-、-COCH=CH-、-CH=N-N=CH-、-CH=CHCOCH2COCH=CH-、-S-、-S-S-、
Figure BDA0002809276590000107
Figure BDA0002809276590000108
Figure BDA0002809276590000111
Figure BDA0002809276590000112
At the E8In which the number of free links includes 2, 3 or 4, in the above-enumerated structures, if E8To which only two rings are attached, then E8The number of free bonds in (1) is 2, e.g.
Figure BDA0002809276590000113
If E8In addition to two rings, there is a third ring or a structure of-E-Q, E8The number of free bonds in (1) is 3, if
Figure BDA0002809276590000114
And the like. If E8In addition to the two rings, there are also other two radicals, then E8The number of free connecting bonds in (1) is 4, e.g.
Figure BDA0002809276590000115
And the like.
Wherein, Z 'is'1is-O-, -S-S-),
Figure BDA0002809276590000116
-COO-、
Figure BDA0002809276590000117
Sulfonyl, sulfonylimino or sulfonyloxy, wherein R41Is H, methyl, ethyl, propyl, isopropyl, butyl, ethoxy, methoxy or a metal ion; r44、R45Independently an alkyl group or a ring; r39、R50Independently selected from H, methyl, ethyl, propyl, butyl, pentyl, cyclopropyl, cyclopentyl, cyclohexyl, nitro, hexyl, thiazole, -CH (CH)3)2、-CH2CH(CH3)2、-CH2CH2NO3
Figure BDA0002809276590000119
Wherein R is8、R40、R46、R47、R48、R49Independently is halogen-free, methyl, nitro or trifluoromethyl, R9Is nothing, methylene, -CH (CH)3)-Ph;R38Selected from among nothing, methyl, ethyl, halogen atoms, fluoromethyl, fluoroethyl or-CH2-N(CH3)2;R37Selected from halogen atom, alkyl, fluoroalkyl, methoxyl, nitryl, aldehyde group, ketone group or ester group.
Further, the general formula I is lithium salt, potassium salt, sodium salt, calcium salt or magnesium salt, namely M in the general formula I comprises Na+、K+、Li+、Mg2+Or Ca2+Preferably a lithium, potassium or sodium salt.
Further, the general formula I is: a compound of formula i as described in any of the preceding paragraphs wherein H on any one of the C groups is substituted, either fully or partially, with halogen, preferably F.
It is another object of the present invention to provide a method for preparing the electrolyte according to any one of the above paragraphs, wherein the method comprises a three-OH-containing bicyclic ternary structure, a three-OH-containing bicyclic ternary structureReacting boron fluoride compound with M source to obtain product containing three-OBF3And (3) a bicyclic boron trifluoride salt of M.
Another aspect of the present invention is to provide an application of the ternary electrolyte containing a bicyclic salt described in any one of the above paragraphs in a secondary battery, where the application is: the general formula I can be used as an additive.
It is a further aspect of the present invention to provide an additive for use in a battery, the additive comprising the general formula I as described in any of the above paragraphs, i.e. comprising a bicyclic boron trifluoride salt as described in any of the above paragraphs.
The invention also provides an electrolyte, which comprises a liquid electrolyte, a gel electrolyte, a mixed solid-liquid electrolyte, a quasi-solid electrolyte and an all-solid electrolyte, wherein the liquid electrolyte, the gel electrolyte, the mixed solid-liquid electrolyte, the quasi-solid electrolyte and the all-solid electrolyte respectively and independently comprise the bicyclic boron trifluoride salt described in any section above, namely the electrolyte comprises the general formula I described in any section above.
The invention also provides a battery, which comprises the ternary electrolyte containing the bicyclic salt, a positive electrode, a negative electrode, a diaphragm and a packaging shell, wherein the ternary electrolyte comprises the bicyclic salt; the battery comprises any one of a liquid battery, a mixed solid-liquid battery, a semi-solid battery, a gel battery, a quasi-solid battery and an all-solid battery.
A final aspect of the present invention is to provide a battery pack including the battery.
The invention has the following main beneficial effects:
the electrolyte in the present application creatively combines three-OBF3M is complexed in a compound, and is preferably-OBF3M is connected with carbon atom C, and the structural effect protected by the invention is more prominent.
Specifically, the boron organic compound can be used as an additive in a battery, can form a stable and compact passivation film on the surface of an electrode of the battery, prevents direct contact between an electrolyte and an electrode active substance, inhibits decomposition of each component of the electrolyte, widens the electrochemical window of the whole electrolyte system, and can remarkably improve the discharge specific capacity, the coulombic efficiency and the cycle performance of the battery; in addition, the boron organic compound is an ionic conductor and is used as an additive, the active ions coming out of the positive electrode are less consumed while a passivation layer is formed on the surface of the electrode, and the first coulombic efficiency and the first cycle discharge specific capacity of the battery can be obviously improved. And when the electrolyte containing the boron organic compound, the existing high-voltage high-specific-volume anode material and the low-voltage high-specific-volume cathode material are compounded into a battery, the electrochemical performance of the battery is improved. In addition, the structure of the application can be mixed with conventional additives for use, namely, a double additive or a multi-additive, and the battery using the double additive or the multi-additive shows more excellent electrochemical performance.
In addition, the structure in the application can be used in the electrolyte, and the structure can also act synergistically as an additive property and a salt property, so that the electrolyte has excellent effect superior to that of the traditional additive, for example, when the structure is used as the additive, a stable passivation layer can be formed on the surface of an electrode in the battery cycling process, PEO or other components are prevented from being further decomposed, and the structure also has good ion transmission performance, so that the battery shows more excellent long-cycle stability and comprehensive effect.
In addition, the boron organic compound has the advantages of rich raw material sources, wide raw material selectivity, low cost, very simple preparation process, simple reaction and mild conditions, and has excellent industrial application prospect, and only a compound containing three-OH groups is required to react with a boron trifluoride organic substance and an M source (M is a metal cation).
In addition, the lithium-ion battery can also adopt metals except traditional lithium such as sodium and potassium to form salts, so that more possibilities are provided for later application, cost control or raw material selection, and the like, and the lithium-ion battery has a great significance.
Drawings
FIGS. 1-10 are nuclear magnetic hydrogen spectra of products of some embodiments of the invention;
fig. 11 to 14 are graphs showing the effect of the circulation of boron trifluoride salt as a liquid electrolyte additive according to the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions of the present invention will be clearly and completely described below with reference to specific embodiments of the present invention, and it is obvious that the described embodiments are some, but not all embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the present invention, unless the position of the substituent to the substituted structure is explicitly indicated, it means that any atom in the substituent may be bonded to the substituted atom or structure, for example: if the substituent is
Figure BDA0002809276590000121
R91、R92Respectively is a substituent on two benzene rings, then any carbon atom and R on any benzene91、R92Or R93(if R is91、R92、R93Not absent) may be attached to a substituted bicyclic structure. Furthermore, where two linkages are present in a substituent, the linked structure may be linked to either linkage, e.g. if R93is-OCH2CH2The linkage on O can be either to the left or to the right phenyl ring, likewise the linkage on methylene is also possible.
In the present invention, if a group is desired to be attached to a two-part structure, it has two linkages or radicals to be attached, and if it is not explicitly indicated which two atoms are attached to the attached part, any one atom containing H may be attached. E if in the claims of this application1Is n-butyl due to E1Having 2 linkages to be linked (one with-OBF)3One to the main structure) and n-butyl has only one bond at the end, then the other bond may be locatedOn any of the 4 carbon atoms in the n-butyl group.
In the context of the present invention, a chemical bond is drawn not on an atom, but on a position where it intersects the bond, e.g. on a line
Figure BDA0002809276590000131
Represents any one H on the ring and may be independently substituted by a substituent A1Substituted, and can replace one H and also can replace two or more H, and the substituents can be the same or different; for example, if a1 is a substituent such as O, methyl, F, etc., then any one or more H may be independently substituted with methyl, F, etc., and any one C containing two H may be linked to O, e.g., it may be
Figure BDA0002809276590000132
And the like.
The "Et" is ethyl. "Ph" is phenyl.
In the title and description of the invention, -OBF3M in M may be a monovalent, divalent, trivalent or polyvalent metal cation, if it is not a monovalent ion, -OBF3The number of (c) is increased correspondingly so that it exactly matches the valence of M.
In the structural formulae of the present invention, when a group in the parentheses "()" is contained after a certain atom, it means that the group in the parentheses is connected to the atom before it. Such as-C (CH)3)2-is of
Figure BDA0002809276590000133
-CH(CH3) -is of
Figure BDA0002809276590000134
In this application, the xx group may have a bond to the substituted structure, or may have two or three, depending on the actual requirement. If it is a general substituent, then it has only one bond, if it is E1、E2Or some R in the first substituent, etc., which has 2 or 3 linkages.
The "boron trifluoride-based compound" refers to boron trifluoride, a compound containing boron trifluoride, a boron trifluoride complex or the like.
The invention provides a ternary organic boron trifluoride salt serving as an electrolyte additive, namely the ternary organic boron trifluoride salt contains three-OBF3M is a group of Li+Or Na+And the like. The ternary boron trifluoride salt can be applied to liquid batteries, and can also be excellently applied to gel batteries and solid batteries. The preparation method of the compound is simple and ingenious, and the yield is high. Namely, the boron trifluoride compound is obtained by reacting a raw material, a boron trifluoride compound and an M source, specifically, -OH in the raw material participates in the reaction, and other structures do not participate in the reaction. The specific preparation method mainly comprises two methods:
adding an M source and a raw material into a solvent in a nitrogen/argon atmosphere, mixing, reacting at 5-50 ℃ for 5-24 hours, and drying the obtained mixed solution at 20-80 ℃ under the vacuum degree of about-0.1 MPa under reduced pressure to remove the solvent to obtain an intermediate; adding boron trifluoride compounds, stirring and reacting at 5-50 ℃ for 6-24 hours, drying the obtained mixed solution under reduced pressure at 30-80 ℃ and under the vacuum degree of about-0.1 MPa to obtain a crude product, and washing, filtering and drying the crude product to obtain the final product, namely the ternary organic boron trifluoride salt, wherein the yield is 74-95%.
Secondly, under the atmosphere of nitrogen/argon, adding the raw materials and boron trifluoride compounds into a solvent, uniformly mixing, reacting for 6-24 hours at the temperature of 5-50 ℃, decompressing and drying the obtained mixed solution at the temperature of 20-80 ℃ and the vacuum degree of about-0.1 MPa to remove the solvent, and reacting to obtain an intermediate; adding an M source into a solvent, then adding the solvent containing the M source into the intermediate, stirring and reacting for 5-24 hours at 5-50 ℃ to obtain a crude product, directly washing the crude product or washing the crude product after drying under reduced pressure, and then filtering and drying to obtain a final product, namely the ternary organic boron trifluoride salt, wherein the yield is 74-95%.
In the above two specific preparation methods, the boron trifluoride compounds may include boron trifluoride diethyl etherate complex, boron trifluoride tetrahydrofuran complex, boron trifluoride dibutyl etherate complex, boron trifluoride acetic acid complex, boron trifluoride monoethyl amine complex, boron trifluoride phosphoric acid complex, and the like. M sources include, but are not limited to, metallic lithium/sodium platelets, lithium/sodium methoxide, lithium/sodium hydroxide, lithium/sodium ethoxide, butyl lithium/sodium, lithium/sodium acetate, and the like. The solvent is independently alcohol (some liquid raw materials can be simultaneously used as the solvent), ethyl acetate, DMF, acetone, hexane, dichloromethane, tetrahydrofuran, ethylene glycol dimethyl ether and the like. The washing can be carried out with a small polar solvent such as diethyl ether, n-butyl ether, n-hexane, cyclohexane, diphenyl ether, etc.
Example 1: raw materials
Figure BDA0002809276590000141
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride tetrahydrofuran complex (4.19g, 0.03mol) were mixed uniformly in 15ml of ethylene glycol dimethyl ether in a nitrogen atmosphere, and reacted at room temperature for 12 hours. The obtained mixed solution is decompressed and dried at 40 ℃ and under the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Dissolving lithium ethoxide (1.56g, 0.03mol) in 10ml ethanol, slowly adding into the intermediate, stirring at 45 deg.C for reaction for 8 hr, drying the obtained mixed solution at 45 deg.C under reduced pressure of about-0.1 MPa to obtain solid, washing with n-butyl ether for three times, filtering, and drying to obtain product M1, wherein Q is OBF3And Li. The yield was 85%, and the nuclear magnetization is shown in FIG. 1.
Example 2: raw materials
Figure BDA0002809276590000142
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride diethyl etherate (4.26g,0.03mol) were mixed uniformly in 15ml of ethylene glycol dimethyl ether under an argon atmosphere, and reacted at room temperature for 12 hours. The obtained mixed solution is decompressed and dried at 30 ℃ and the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Adding 18.90ml of butyl lithium hexane solution (c is 1.6mol/L) into the intermediate, stirring at room temperature for 6 hours, washing the obtained mixed solution with xylene for 3 times, drying under reduced pressure at 40 deg.C and a vacuum degree of about-0.1 MPa, washing the obtained crude product with cyclohexane for 3 times, filtering, and dryingObtaining a product M2, wherein Q is OBF3And Li. The yield was 87%.
Example 3: raw materials
Figure BDA0002809276590000143
The preparation method comprises the following steps: 0.01mol of the starting material and lithium methoxide (1.14g,0.03mol) were mixed uniformly with 20ml of methanol under a nitrogen atmosphere, and reacted at room temperature for 8 hours. The obtained mixed solution is decompressed and dried at 40 ℃ and under the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Adding boron trifluoride tetrahydrofuran complex (4.19g, 0.03mol) into the intermediate, stirring at room temperature for reaction for 6 hours, drying the obtained mixed solution under reduced pressure at 40 ℃ and under the vacuum degree of-0.1 MPa, washing the obtained solid with isopropyl ether for three times, filtering and drying to obtain a product M3, wherein Q is OBF3And Li. Yield 88%, nuclear magnetization is shown in figure 2.
Example 4: raw materials
Figure BDA0002809276590000144
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride tetrahydrofuran complex (4.19g, 0.03mol) were mixed uniformly in 15ml of ethylene glycol dimethyl ether under an argon atmosphere, and reacted at room temperature for 12 hours. The resulting mixed solution was dried under reduced pressure at 30 ℃ and a vacuum of about-0.1 MPa to remove the solvent, and an intermediate was obtained. Adding 18.90ml of butyl lithium hexane solution (c is 1.6mol/L) into the intermediate, stirring and reacting for 6 hours at room temperature, washing the obtained mixed solution for 3 times by using dimethylbenzene, drying under reduced pressure at 40 ℃ and the vacuum degree of about-0.1 MPa, washing the obtained crude product for 3 times by using cyclohexane, filtering and drying to obtain a product M4, wherein Q is OBF3And Li. The yield was 84%, and the nuclear magnetization is shown in FIG. 3.
Example 5: raw materials
Figure BDA0002809276590000151
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride-acetic acid complex (5.63g, 0.03mol) were placed in 15ml of ethylene glycol under an argon atmosphereUniformly mixing the dimethyl ether, reacting for 12 hours at 40 ℃, and drying the obtained mixed solution under reduced pressure at 40 ℃ and under the vacuum degree of about-0.1 MPa to remove the solvent to obtain an intermediate. Dissolving sodium acetate (2.46g, 0.03mol) in 10ml of N, N-dimethylformamide, adding into the intermediate, stirring at 50 deg.C for 8 hr, drying the obtained mixture under reduced pressure at 80 deg.C and vacuum degree of-0.1 MPa to obtain solid, washing with diphenyl ether three times, filtering, and drying to obtain product M5, wherein Q is OBF3And (4) Na. The yield was 85%, and the nuclear magnetization is shown in FIG. 4.
Example 6: raw materials
Figure BDA0002809276590000152
Preparation: the product M6 was prepared from the starting material by the method of example 2, wherein Q is OBF3And Li. The yield was 89%.
Example 7: raw materials
Figure BDA0002809276590000153
Preparation: the product M7 was prepared from the starting material by the method of example 1, wherein Q was OBF3And Li. Yield 82%, nuclear magnetization is shown in fig. 5.
Example 8: raw materials
Figure BDA0002809276590000154
Preparation: the product M8 was prepared from the starting material by the method of example 4, wherein Q is OBF3And Li. The yield was 80%.
Example 9: raw materials
Figure BDA0002809276590000155
Preparation: the product M9 was prepared from the starting material by the method of example 1, wherein Q is OBF3And Li. Yield 79% and nuclear magnetization are shown in fig. 6.
Example 10: raw materials
Figure BDA0002809276590000156
Preparation: the product M10 was prepared from the starting material by the method of example 3, wherein Q is OBF3And Li. Yield 81%, nuclear magnetization is shown in fig. 7.
Example 11: starting materials
Figure BDA0002809276590000161
Preparation: the product M11 was prepared from the starting material by the method of example 2, wherein Q is OBF3And Li. Yield 86%, nuclear magnetization is shown in fig. 8.
Example 12: raw materials
Figure BDA0002809276590000162
Preparation: the product M12 was prepared from the starting material by the method of example 3, wherein Q is OBF3And Li. The yield was 90%.
Example 13: raw materials
Figure BDA0002809276590000163
Preparation: the product M13 was prepared from the starting material by the method of example 2, wherein Q is OBF3And Li. Yield 88%, nmr is shown in figure 9.
Example 14: raw materials
Figure BDA0002809276590000164
Preparation: the product M14 was prepared from the starting material by the method of example 1, wherein Q is OBF3And Li. Yield 84%, nmr is shown in figure 10.
Example 15: raw materials
Figure BDA0002809276590000165
Preparation: the product M15 was prepared from the starting material by the method of example 1, wherein Q is OBF3And Li. The yield was 84%.
Example 16
The protected bicyclic boron trifluoride salt is mainly used as an additive, mainly plays a role in generating a stable passivation layer, and has ions capable of being dissociated, so that the ions provided by an electrode are less consumed in the process of forming the passivation layer, and the first effect and the cycle performance of the battery are obviously improved. The performance of the invention is illustrated in experimental manner below.
(1) Positive pole piece
Adding the active substance of the main anode material, the electronic conductive additive and the binder into a solvent according to the mass ratio of 95:2:3, wherein the solvent accounts for 65% of the total slurry by mass percent, and uniformly mixing and stirring to obtain anode slurry with certain fluidity; and coating the anode slurry on an aluminum foil, drying, compacting and cutting to obtain the usable anode piece. Lithium cobaltate (LiCoO) is selected as the active material2LCO for short), lithium nickel cobalt manganese oxide (NCM811 for selection), lithium nickel cobalt aluminate (LiNi)0.8Co0.15Al0.05O2Abbreviated NCA) and lithium nickel manganese oxide (LiNi)0.5Mn1.5O4Abbreviated LNMO), Na0.9[Cu0.22Fe0.3Mn0.48]O2(NCFMO for short), Carbon Nanotubes (CNT) and Super P are selected as the electron conductive additive, polyvinylidene fluoride (PVDF) is used as the binder, and N-methylpyrrolidone (NMP) is used as the solvent.
(2) Negative pole piece
Adding a main negative material active substance (except metal Li), an electronic conductive additive and a binder into solvent deionized water according to a ratio of 95:2.5:2.5, wherein the solvent accounts for 42% of the total slurry, and uniformly mixing and stirring to obtain negative slurry with certain fluidity; and coating the negative electrode slurry on copper foil, drying and compacting to obtain the usable negative electrode piece. Graphite (C), silicon carbon (SiOC450), metallic lithium (Li) and Soft Carbon (SC) are selected as the active materials, CNT and Super P are used as the conductive agents, and carboxymethyl cellulose (CMC) and Styrene Butadiene Rubber (SBR) are used as the binders.
The anode and cathode systems selected by the invention are shown in table 1:
TABLE 1 Positive and negative electrode system
Positive and negative electrode system of battery Positive electrode main material Negative electrode main material
A1 LCO SiOC450
A2 NCM811 SiOC450
A3 NCM811 Li
A4 NCA C
A5 LNMO C
A6 LCO Li
A7 NCFMO SC
(3) Preparing liquid electrolyte
M1-M15, an organic solvent, a conventional salt and a conventional additive are uniformly mixed to obtain series electrolytes E1-E15, wherein the used solvents are Ethyl Methyl Carbonate (EMC), dimethyl carbonate (DMC), diethyl carbonate (DEC), Ethylene Carbonate (EC) and Propylene Carbonate (PC). Conventional additives are fluoroethylene carbonate (FEC), Vinylene Carbonate (VC), trimethyl phosphate (TMP), ethoxypentafluorocyclotriphosphazene (PFPN), vinyl sulfate (DTD); conventional salts are lithium bis (oxalato) borate (LiBOB), lithium difluoro (oxalato) borate (LiODFB), lithium bis (fluorosulfonylimide) (LiFSI), lithium hexafluorophosphate (LiPF)6) Lithium bis (trifluoromethyl) sulfonimide (LiTFSI), sodium hexafluorophosphate (NaPF)6). The specific components and ratios are shown in table 2.
Table 2 electrolytes formulated as additives in the present application
Figure BDA0002809276590000171
Figure BDA0002809276590000181
Note: 1M means 1 mol/L.
Comparison sample: and replacing M1-M15 with blanks according to the proportion of E1-E15 (namely, not adding M1-M15), thus obtaining corresponding conventional electrolyte comparison samples L1-L15.
(4) Button cell assembly
Electrolyte series E1-E15 containing the structure of the embodiment as an additive and conventional electrolytes L1-L15 are assembled into a button cell in a comparative way, and the details are as follows: negative electrode shell, negative electrode pole piece, PE/Al2O3A button cell is assembled by a diaphragm, an electrolyte, a positive pole piece, a stainless steel sheet, a spring piece and a positive shell, and a long circulation test is carried out at room temperature, wherein the circulation modes are 0.1C/0.1C 1 week, 0.2C/0.2C 5 week and 1C/1C 44 week (C represents multiplying power), the positive pole piece is a circular sheet with the diameter of 12mm, the negative pole piece is a circular sheet with the diameter of 14mm, and the diaphragm is a circular sheet with the diameter of 16.2mmWafer of commercial Al2O3a/PE porous separator.
The battery systems prepared from E1 to E15 were batteries 1 to 15, respectively, and the battery systems prepared from L1 to L15 were comparative batteries 1 to 15, respectively. The specific configuration and voltage range of the cell are shown in table 3. The results of the first cycle specific discharge capacity, the first cycle efficiency, and the capacity retention rate at 50 cycles of the batteries 1 to 15 and the comparative batteries 1 to 15 at room temperature are shown in table 4.
Table 3 arrangement and test mode of example and comparative example cells
Figure BDA0002809276590000182
Table 4 comparison of test results for example cells and comparative example cells
Figure BDA0002809276590000183
Figure BDA0002809276590000191
From the test results of the battery and the comparative battery, in the button battery, when the positive and negative electrode systems are the same, the first cycle efficiency, the discharge specific capacity and the capacity retention rate of the lithium/sodium battery using the structures M1-M15 as the liquid electrolyte additive are much better than those of the lithium/sodium battery without the additive, and the performance of the lithium/sodium battery is superior to that of the conventional additive at present. Furthermore, cells using the boron trifluoride salt additives herein exhibit superior electrochemical performance in the presence of conventional additives.
In addition, the application also shows the effect graph of some examples as additives. Fig. 11-14 are graphs comparing the performance of battery 1/2/5/15 made as a liquid electrolyte additive in accordance with example 1/2/5/15 with a corresponding comparative battery 1/2/5/15 that did not include an example of the present invention. The figures also show that the structure of the application has excellent effect. In addition, in the circulation diagram, there are small squares on the upper sideBlock
Figure BDA0002809276590000192
The lines of (A) represent the cells of the examples, with small circles
Figure BDA0002809276590000193
The lines representing the comparative example cells indicate that the example cells are all above the lines representing the comparative example cells, and the example cells are more excellent.
The first cycle efficiency, specific discharge capacity, capacity retention rate and other properties have direct and significant influence on the overall performance of the battery, and directly determine whether the battery can be applied or not. Therefore, it is the goal or direction of many researchers in this field to improve these properties, but in this field, the improvement of these properties is very difficult, and generally about 3-5% improvement is a great progress. In the early experimental data, the data are surprisingly found to be greatly improved compared with the conventional data, particularly when the additive is used as an electrolyte additive, the performance is improved by about 5-30%, and the additive and the conventional additive are combined to be used for showing better effect. More importantly, the structural type of the application is greatly different from the conventional structure, so that a new direction and thought are provided for the research and development in the field, a large space is brought for further research, and the application can also have multiple purposes; has great significance.
Example 17:
for further study and understanding of the structural properties in the present application, the applicant evaluated the effect of the following 2 structures as liquid electrolyte additives on the long cycle performance of the battery at room temperature. The structure of the present application was selected from the structure in example 1 (i.e., M1), and the following 2 comparative example structures were structure W1 and structure W2, respectively.
Figure BDA0002809276590000201
The effects of W1-W2 and M1 on the long-cycle performance of the cell at room temperature were evaluated by using them as liquid electrolyte additives, respectively.
(1) Liquid electrolyte configuration
TABLE 5 electrolytes S1 to S3 with W1 to W2 and M1 as additives
Figure BDA0002809276590000202
Wherein S0 is a control group.
(2) Button cell assembly
The obtained liquid electrolytes S0 to S3 were assembled into button cells, and the sizes of the positive and negative electrodes, the separator, the assembly method, and the battery cycle were the same as those of the button cell shown in "one" of example 16, i.e., batteries Y0 to Y3, respectively. The specific configuration, cycling profile and voltage range of the cell are shown in table 6 and the test results are shown in table 7.
TABLE 6 Battery Assembly and test mode
Figure BDA0002809276590000203
TABLE 7 test results of the batteries
Figure BDA0002809276590000204
The test results of the batteries Y0-Y3 show that the first efficiency, the 1-50-week discharge specific capacity and the capacity retention rate of the batteries can be improved by using the batteries W1-W2 and M1 as liquid electrolyte additives. However, compared with W1-W2, M1 has more obvious improvement on the first efficiency and first cycle specific discharge capacity of the battery, probably because W1 contains 1-OBF3M, W2 is a complex, no bond, chemically unstable and free of lithium, and contains three-OBF3M1 of the lithium ion battery contains a lithium source, and lithium ions removed from the positive electrode are less consumed in the process of forming a good passivation layer, so that the first-effect, first-cycle discharge specific capacity and capacity retention rate of the battery are excellent. The applicant is still in further research with a clearer and more clear mechanism. But no matter whetherIn any case, it is certain that the OBF3The presence and amount of M has a substantial effect on battery performance.
In the present invention, the structures in examples 1 to 15 were selected as representative to explain the production method and effects of the present application. Other structures not shown are all very effective and similar to examples 1-15, and other structures not shown can be prepared by the method described in any of examples 1-5. The preparation method is that the raw material, boron trifluoride compounds and M source react to obtain the product boron trifluoride organic salt, namely-OH in the raw material is changed into-OBF3M, M may be Li+、Na+Etc., and the other structures are not changed. In addition, many research teams of the applicant have already made serial effect tests, which are similar to the effect in the above embodiments, such as: from raw materials
Figure BDA0002809276590000211
Figure BDA0002809276590000212
Figure BDA0002809276590000213
Etc., the boron trifluoride salt of the present application is excellent in effect, but only partial structure and data are given due to space relation.
In the present invention, it is also noted that (i) -OBF3-BF of M3It must be bonded to the oxygen atom O, which is in turn bonded by a single bond to the carbon atom C, so that O cannot be a ring-located oxygen. If O is bonded to N, S or another atom, or if O is located on a ring (or if O is bonded to another two groups), the structure is greatly different from the present application, and therefore, it cannot be predicted whether such a structure can be applied to the electrolyte of the present application, what effects and application scenarios are expected, and therefore, the inventors of the present invention will conduct independent studies on these structures, and will not conduct much discussion here; ② the structure does not contain sulfydryl. ③ the bicyclic boron trifluoride salts are preferably in a non-polymeric stateThe organic, polymeric state has its unique characteristics and features, and the applicant may later develop specific studies on the polymeric state, which is referred to herein as the non-polymeric state.
In the present application, the above three cases are all required to be satisfied, and if not, the properties of the present application are greatly different, so that the application scene or effect after change is not well predicted, and may be greatly changed, and if valuable, the present inventors will perform special research separately later.
It should be noted that, the applicant has performed a great number of tests on the series of structures, and sometimes, for better comparison with the existing system, there are cases where the same structure and system are tested more than once, and therefore, there may be some error in the tests performed at different times.
In addition, the raw materials of the present invention can be obtained by purchase or simple preparation, which is extremely fundamental in the field of organic chemistry, and there is no difficulty, so that the structure of the raw materials or the synthesis of the raw materials is conventional and not described much, which is out of the scope of the present invention.
Finally, it should be noted that: the above-mentioned embodiments are only used for illustrating the technical solution of the present invention, and not for limiting the same; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.

Claims (13)

1. A ternary electrolyte comprising a bicyclic salt, wherein: the electrolyte comprises a bicycloheteroboron trifluoride salt represented by the following general formula I:
Figure FDA0002809276580000011
in the above general formula IR and R1Represents a ring comprising a single ring and a multiple ring composed of at least two single rings; e8Is a chain containing no, at least one atom or a structure containing a ring; when E is8When not present, R and R1By a single or double bond;
m is a metal cation;
E4is a chain without or containing at least one atom;
-E3-OBF3m is connected to E4、E8R or R1On any one atom of;
E1、E2、E3independently a chain structure or a structure containing a ring, which is free of, contains at least one atom;
r' and R1' independently is a substituent, any one H on the representative ring may be substituted by a substituent, and the substituent may be substituted for one H or two or more H, and if two or more H are substituted, the substituents may be the same or different.
2. The ternary electrolyte comprising a bicyclic salt according to claim 1, wherein: in the general formula I, E8By single or double bonds with R and R1Connecting;
the monocyclic ring is a three-to twenty-membered ring and comprises a saturated carbocycle, a saturated heterocycle, an unsaturated carbocycle and an unsaturated heterocycle; saturated, unsaturated heterocyclic rings are rings containing at least one heteroatom selected from O, N, P, Si, Se, B, S, Se or Al;
the polycyclic ring composed of a single ring includes a parallel ring, a bridged ring, a spiro ring, and a ring containing at least two of the three polycyclic rings; the fused ring is formed by combining more than 2 single rings together, and two adjacent atoms on one ring share with two adjacent atoms on the other ring in the two fused rings; the bridge ring is a polycyclic structure sharing more than two atoms; the spiro ring shares one atom with two adjacent monocyclic rings.
3. The birch-containing compound of claim 2A salt-like ternary electrolyte characterized by: in the general formula I, with-OBF3The atoms to which M is directly connected include C, S, N, Si, P, B or O; preferably with said-OBF3The atom to which M is attached is a carbon atom C;
preferably, H on any one C in said formula i may be independently substituted by halogen.
4. The ternary electrolyte comprising a bicyclic salt according to claim 3, wherein: the substituents R' and R1' independently include H, a halogen atom, an etheroxy group, an etherthio group, a nitro group, a cyano group, a C ═ O containing substituent, an O ═ S ═ O containing substituent, an N containing substituent, an alkyl group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, an alkynyl group, a heteroalkynyl group, an alkenylalkynyl group, a heteroalkynyl group, an O ═ S, a nitro group, a cyano group, a C ═ O containing substituent, a O ═ S ═ O substituent, a N containing substituent, an alkyl group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, an alkynyl group, an alkenylalkynyl group, a heteroalkynyl group, a hetero alkenylalkynyl group, a hetero alkynyl group, a,
Figure FDA0002809276580000012
A salt substituent, a cyclic substituent, and a group in which H on any one of C of these groups is substituted with a halogen atom;
preferably, the cyclic substituent includes a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring and a polycyclic substituent having two or more ring structures at the same time; r5、R6Independently H, alkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, and heteroalkynyl; such salt substituents include, but are not limited to, sulfate, sulfonate, sulfonimide, carbonate, carboxylate, ether, nitrogen, silicate, phosphate, hydrochloride, nitrate, azide; any one of the structures of heteroalkane/alkene/alkyne/alkenynyl contains at least one non-carbon atom selected from halogen, S, N, O, P, Se, Ca, Al, B, or Si;
the first substituent can be optionally bonded to an atom of each of the above substituents.
5. The tricyclic salt-containing ternary electrolyte of claim 4, wherein: e1、E2Or E3Independently selected from the group consisting of none, carbonyl, ester, alkaneA group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, a group containing a cyclic structure,
Figure FDA0002809276580000013
Or ═ N-R7’-;
E4Is a chain structure without or containing 3 free connecting bonds, and the 3 free connecting bonds are respectively connected with a ring and E1And E3Connecting;
E8is nothing, ether oxygen group, ether sulfur group, carbonyl group, ester group, phosphate group, alkyl group, heteroalkyl group, alkenyl group, heteroalkenyl group or cyclic group, and the cyclic group comprises
Figure FDA0002809276580000021
and-R52-R51-R53-,R51Is a first monocyclic ring, a first fused ring or a first linked ring, wherein the first linked ring contains at least two monocyclic rings, adjacent monocyclic rings are linked by a single bond or by a chain containing at least one atom, R is52And R53Independently a chain containing no or at least one atom;
Figure FDA0002809276580000022
represents a second monocyclic ring or a second fused ring, R50Represents an atom in a second monocyclic ring or a second fused ring, the atom containing two atoms which are respectively associated with R and R1A linked key;
wherein the double bond in the heteroalkenyl group includes a structure containing a carbon-carbon double bond C ═ C and a structure containing a carbon-nitrogen double bond C ═ N, and R is5’、R6' and R7' independently of R in claim 45、R6The species defined in (1) are identical.
6. The tricyclic salt-containing ternary electrolyte of claim 5, wherein:
the monocyclic ring includes a saturated carbocyclic ring, a saturated heterocyclic ring, an unsaturated carbocyclic ring and an unsaturated heterocyclic ring, and the monocyclic ring is a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a nine-membered ring, a ten-membered ring, a twelve-membered ring, a fourteen-membered ring, a sixteen-membered ring or an eighteen-membered ring;
wherein the tri-unsaturated carbocyclic ring comprises a1 double-bonded carbocyclic ring; a ternary saturated heterocycle includes a saturated ring containing 1 or 2 heteroatoms; the ternary unsaturated heterocycle comprises 1 double bond and simultaneously contains 1 or 2 heteroatoms;
the quaternary unsaturated carbocycle includes carbocycles containing 1 double bond or 2 double bonds, and if 2 double bonds, they are not adjacently disposed; a quaternary saturated heterocycle includes a saturated ring containing 1 or 2 heteroatoms; the quaternary unsaturated heterocycle is a four-membered ring which contains 1 or 2 double bonds and simultaneously contains 1 or 2 heteroatoms;
five-membered unsaturated carbocycles include carbocycles containing 1 double bond or 2 double bonds, and if 2 double bonds, they are not disposed adjacent; a five-membered saturated heterocycle includes a saturated ring containing 1,2, 3, or 4 heteroatoms; the five-membered unsaturated heterocycle is a five-membered ring which contains 1 or 2 double bonds and simultaneously contains 1,2, 3 or 4 heteroatoms;
six-membered unsaturated carbocycles include carbocycles containing 1,2 or 3 double bonds, and if 2 or 3 double bonds, are non-adjacent to each other; six membered saturated heterocyclic rings include saturated rings containing 1,2, 3 or 4 heteroatoms; the six-membered unsaturated heterocycle is a six-membered ring which contains 1,2 or 3 double bonds and simultaneously contains 1,2, 3, 4, 5 or 6 heteroatoms;
the seven-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2 or 3 double bonds, and if 2 or 3 double bonds are contained, the two carbocyclic rings are arranged non-adjacently; a seven membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3 or 4 heteroatoms; the seven-membered unsaturated heterocycle is a seven-membered ring which contains 1,2 or 3 double bonds and simultaneously contains 1,2, 3 or 4 heteroatoms;
the eight-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2, 3 or 4 double bonds, and if 2 or more double bonds are present, the two double bonds are not adjacent to each other; an eight membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3 or 4 heteroatoms; an eight-membered unsaturated heterocycle is an eight-membered ring containing 1,2, 3 or 4 double bonds and simultaneously 1,2, 3 or 4 heteroatoms;
the nine-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2, 3 or 4 double bonds, and if 2 or more double bonds are present, the two double bonds are not adjacent to each other; a nine membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3 or 4 heteroatoms; the nine-membered unsaturated heterocycle is a nine-membered ring which contains 1,2, 3 or 4 double bonds and simultaneously contains 1,2, 3 or 4 heteroatoms;
the ten-membered unsaturated carbocyclic ring comprises a carbocyclic ring containing 1,2, 3 or 4 double bonds, and if 2 or more double bonds are present, the two are arranged non-adjacently; a ten-membered saturated heterocyclic ring includes a saturated ring containing 1,2, 3, or 4 heteroatoms; the ten-membered unsaturated heterocycle is a ten-membered ring containing 1,2, 3 or 4 double bonds and simultaneously containing 1,2, 3 or 4 heteroatoms;
the twelve-membered ring, the fourteen-membered ring, the sixteen-membered ring and the eighteenth-membered ring respectively and independently comprise a saturated carbon ring, a saturated heterocyclic ring containing 1,2, 3, 4, 5 or 6 heteroatoms and an unsaturated heterocyclic ring, wherein the unsaturated heterocyclic ring is a ring containing 1,2, 3, 4, 5 or 6 heteroatoms and simultaneously containing 1,2, 3, 4, 5 or 6 unsaturated bonds;
the polycyclic ring is formed by combining more than 2-5 single rings; any one of the monocyclic ring or polycyclic ring is connected with the substituent R' or R1’;
Any one heteroatom on the above heterocyclic ring is independently selected from O, N, P, Si or S.
7. The tricyclic salt-containing ternary electrolyte of claim 6, wherein: the monocyclic ring is selected from the following rings: cyclopropane, cyclopropene, ethylene oxide, cyclobutane,
Figure FDA0002809276580000031
Cyclobutene, cyclopentane, cyclopentene, cyclopentadiene, pyrrole, dihydropyrrole, tetrahydropyrrole, furan, dihydrofuran, tetrahydrofuran, thiophene, dihydrothiopheneTetrahydrothiophene, imidazole, pyrazole, thiazole, dihydrothiazole, oxazole, dihydrooxazole, isoxazole, dihydroisoxazole, triazole, dihydrotriazole, tetrazole, benzene ring, pyridine, dihydropyridine, tetrahydropyridine, pyrimidine, pyrazine, pyridazine, p-diazabenzene, triazine, cyclohexane, dioxane, cyclohexene, 1, 3-cyclohexadiene, 1, 4-cyclohexadiene, piperidine, pyran, dihydropyran, tetrahydropyran, dihydrothiopyran, tetrahydrothiopyran, dithiane, 1, 2-dithiane, [1, 3-dithiane]Oxazolidines, morpholines, piperazines, pyrones, dihydropyrimidines, tetrahydropyrimidines, hexahydropyrimidines, cycloheptanes, epoxyhexanes, cycloheptenes, 1, 3-cycloheptenes, 1,3, 5-cycloheptenes, cyclooctanes, cyclononanes, cyclononanatrienes, cyclododecanes, 1,5, 9-triazacyclododecanes, pentazocines, and combinations thereof,
Figure FDA0002809276580000032
Figure FDA0002809276580000033
Figure FDA0002809276580000034
Or 18-crown-6;
the polycyclic ring is composed of the above-mentioned monocyclic ring.
8. The tricyclic salt-containing ternary electrolyte of claim 7, wherein: included for said formula I are, but not limited to, the following compounds:
Figure FDA0002809276580000035
Figure FDA0002809276580000041
Figure FDA0002809276580000051
in the above structure, Q1、Q2、Q3homo-OBF3M; e in each ring structure1、E2、E3Independently of each other, as defined in any one of claims 1 to 7; e in each ring structure8Are each independently as defined in any one of claims 1 to 6E8The consistency is achieved; any one H on each ring can be independently selected from A1、A2、A3Or A4Any one substituent of (A), A1、A2、A3Or A4Are each independently selected from the substituents R' or R as defined in any one of claims 1 to 71' any one substituent defined in (1).
9. The ternary electrolyte comprising a bicyclic salt according to any one of claims 4 to 8, wherein: the substituents R' and R1’、A1、A2、A3Or A4Independently selected from H, halogen atom, carbonyl, ester group, aldehyde group, ether oxygen group, ether sulfur group, ═ O, ═ S,
Figure FDA0002809276580000052
Nitro, cyano, amino, amide, sulfonamide, sulfoalkane, hydrazino, diazo, alkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, alkenylalkynyl, heteroalkynyl, cyclic substituents and substituents of said salts; wherein ester groups include carbonates, carboxylates, sulfonates, and phosphates;
preferably, in the substituent, the halogen atom comprises F, Cl, Br, I, and the carbonyl group is-R10COR11The ester group is-R12COOR13、-R12OCOR17、-R12SO3R13、R12O-CO-OR13Or
Figure FDA0002809276580000053
The ether oxygen radical is-R14OR15The etherthio radical is-R14SR15Amino is ═ N-R20
Figure FDA0002809276580000054
or-CH ═ N-R24Amide is
Figure FDA0002809276580000055
Or
Figure FDA0002809276580000056
Sulfonamide group of
Figure FDA0002809276580000057
The sulfoalkane is-R18SO2R19The diazo group is-N ═ N-R38Salt substituents include, but are not limited to, sulfate, sulfonate, sulfonimide, carbonate, carboxylate, nitrate;
wherein R is5、R6、R10、R11、R12、R13、R14、R15、R16、R17、R18、R19、R20、R21、R22、R23、R24、R25、R26、R27、R28、R29、R30、R31、R32、R33、R34、R35、R38Independently is C1-10Alkyl radical, C1-10Heteroalkyl group, C1-10Alkenyl radical, C1-10Heteroalkenyl, C1-10Alkynyl, C1-10Heteroalkynyl, heteroalkenyl/alkynyl being a heteroalkenyl/alkenyl/alkynyl group bearing at least one of the non-carbon atoms; the group directly bound to N or O can also be a metal ion, R5、R6、R10、R12、R14、R18、R20、R21、R22、R23、R24、R25、R26、R27、R29、R30、R33、R35、R38May independently be H or none;
cyano radicals selected from-CN, -CH2CN、-SCH2CH2CN、-N(CH3)CH2CH2CN or-CH2CH2CN。
The alkyl group includes methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, or octadecyl; heteroalkyl is an alkyl group containing at least one of the heteroatoms;
the alkenyl group includes vinyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl; heteroalkenyl is alkenyl containing at least one of the heteroatoms; the alkynyl group comprises ethynyl, propynyl, butynyl, pentynyl, hexynyl or heptynyl; heteroalkynyl is an alkynyl group containing at least one of the heteroatoms; the alkenylalkynyl group is a structure containing at least one double bond and at least one triple bond; said heteroalkynyl is an alkynyl containing at least one of said heteroatoms;
the cyclic substituents include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and polycyclic rings;
preferably, any one ring of the ring substituents is independently linked to the substituted bicyclic ring by any one of the following linking groups: -CH2-、-CH2CH2-、-CH2CH2CH2-、-CH(CH3) -, butyl, ethylene, propylene, butene, acetylene, propyne, -COO-, -CO-, -SO2-、-N=N-、-O-、-OCH2-、-OCH2CH2-、-CH2OCH2-、-COCH2-、-CH2OCH2CH2-、-OCH2CH2O-、-COOCH2CH2-、-S-、-S-S-、-CH2OOC-、-CH=CH-CO-、-COOCH2OCOCH2-、
Figure FDA0002809276580000061
Or a single bond; r42Independently selected from H, methyl, ethyl or propyl; r36、R37、R42Independently selected from H, methyl, ethyl, propyl, isopropyl, butyl, fluoromethyl, fluoroethyl, methoxy, ethenyl, propenyl, or a metal ion; r83Selected from alkyl or cyclic;
any atom with H on any ring of the above ring substituents can be selectively connected with the first substituent; the first substituent is selected from H, halogen atom, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, fluoromethyl, fluoroethyl, methoxy, ethoxy, nitro, alkenyl, alkynyl, ester group, sulfonate, sulfoalkane, amido, cyano, aldehyde group, -SCH3、-COOCH3、COOCH2CH3、-OCF3、=O、=S、-N(CH3)2、-CON(CH3)2、-SO2CH3、-SO2CH2CH3Or a substituent wherein H on any one C of these groups is substituted with a halogen.
10. The tricyclic salt-containing ternary electrolyte of claim 8, wherein: e1、E2Or E3Independently selected from the group consisting of none, carbonyl, keto, ester, -CH2-、-CH2CO-, ethyl, N-propyl, isopropyl, N-butyl, isobutyl, N-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, ethenyl, propenyl, butenyl, pentenyl, hexenyl, octenyl, nonenyl, decenyl, ethynyl, propynyl, butynyl, cyclohexyl, cyclopentyl, 1, 3-hexadienyl, -C ═ N-, -C (CH)3)2-、-CH(CH3)-、-CH(CF3)-、-C(CF3)2-、-CH2CH2CH(CH3)-、-Z'1CH2CH2-、-CH=CH-CO-、-OCH2CH2CH2CO-、=N-CH2-CO-、-Z'1CH2CO-、-Z'1CH2CH2CO-、-Z'1CH2CH2CH2CO-、-COOCH2CH2-、-O-CH2(CH2)4CH2-、-CH2CH2CO-、-CH2CH(CH3)-、-OCH2-、-CH(CH3)CO-、-CH(CH2Cl)-、-CH(OCH3)-、-CH(CHO)-、-CH2COCO-、-C(CH3)2CH2CH2-、-CH2(CH2)5CO-、-CH2(CH2)6CO-、-N=C(CH3)-、-O-(CH2)6-、-CH2Z'1CH2-、-CH2(CH3)Z'1CH2-、-CH2CH2Z'1CH2-、
Figure FDA0002809276580000062
Figure FDA0002809276580000063
Figure FDA0002809276580000064
-(CH3)CHCH2CH2Z’1CH2-、-O-CH(CH3)-(CH2)4CH2-、
Figure FDA0002809276580000065
Figure FDA0002809276580000066
E8Is selected from-CH, -CH2-、-CH2CH2-、-C(CH3)2-、-CH(CH3)-、-CH(CH3)CH(CH3)-、-CH(Et)CH(Et)-、=CH-CH=、-CH2CH(CH3)-、-CO-、-O-、COO-、-OCH2O-、-CH=CH-、-COCH=CH-、-CH=N-N=CH-、-CH=CHCOCH2COCH=CH-、-S-、-S-S-、
Figure FDA0002809276580000071
Figure FDA0002809276580000072
Wherein Z 'of claim'1is-O-, -S-S-),
Figure FDA0002809276580000073
-COO-、
Figure FDA0002809276580000074
Sulfonyl, sulfonylimino or sulfonyloxy, wherein R41Is H, methyl, ethyl, propyl, isopropyl, butyl, ethoxy, methoxy or a metal ion; r is44、R45Independently an alkyl group or a ring;
R39、R50independently selected from H, methyl, ethyl, propyl, butyl, pentyl, cyclopropyl, cyclopentyl, cyclohexyl, nitro, hexyl, thiazole, -CH (CH)3)2、-CH2CH(CH3)2、-CH2CH2NO3
Figure FDA0002809276580000075
Wherein R is8、R40、R46、R47、R48、R49Independently is halogen-free, methyl, nitro or trifluoromethyl, R9Is nothing, methylene, -CH (CH)3)-Ph;R38Selected from among nothing, methyl, ethyl, halogen atoms, fluoromethyl, fluoroethyl or-CH2-N(CH3)2;R37Selected from halogen atom, alkyl, fluoroalkyl, methoxyl, nitryl, aldehyde group, ketone group or ester group.
11. The ternary electrolyte comprising a bicyclic salt according to any one of claims 1 to 10, wherein: the general formula I is lithium salt, potassium salt, sodium salt, calcium salt or magnesium salt, preferably lithium salt, potassium salt or sodium salt;
the general formula I is as follows: a compound of formula i according to any one of claims 1-10 wherein H on any one C is substituted, wholly or partially, with halogen, preferably F.
12. A method for producing an electrolyte according to any one of claims 1 to 11, characterized in that: the method comprises the step of reacting a three-OH-contained catenated ring ternary structure, a boron trifluoride compound and an M source to obtain a product, namely the product contains three-OBF3And (3) a bicyclic boron trifluoride salt of M.
13. Use of the ternary electrolyte containing a bicyclic salt according to any one of claims 1 to 11 in a secondary battery, characterized in that: the application is as follows: the bicyclic boron trifluoride salt shown in the general formula I can be used as an additive;
preferably, the application comprises application in liquid electrolytes, gel electrolytes, mixed solid-liquid electrolytes, quasi-solid electrolytes, all-solid electrolytes, which each independently comprise a bicyclic boron trifluoride salt according to any one of claims 1 to 11.
Preferably, the application further comprises the application as a battery or a battery pack, wherein the battery comprises the ternary electrolyte containing the bicyclic salt and a positive electrode, a negative electrode, a separator and a packaging shell; the battery comprises any one of a liquid battery, a mixed solid-liquid battery, a semi-solid battery, a gel battery, a quasi-solid battery and an all-solid battery;
the battery pack includes the battery.
CN202011380868.0A 2020-11-30 2020-11-30 Ternary electrolyte containing bicyclic salt and preparation method and application thereof Withdrawn CN114573616A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011380868.0A CN114573616A (en) 2020-11-30 2020-11-30 Ternary electrolyte containing bicyclic salt and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011380868.0A CN114573616A (en) 2020-11-30 2020-11-30 Ternary electrolyte containing bicyclic salt and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN114573616A true CN114573616A (en) 2022-06-03

Family

ID=81768839

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011380868.0A Withdrawn CN114573616A (en) 2020-11-30 2020-11-30 Ternary electrolyte containing bicyclic salt and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114573616A (en)

Similar Documents

Publication Publication Date Title
CN105870505A (en) Electrolyte and secondary battery containing same
CN114649581B (en) Electrolyte containing five-membered cyclic nitrogen-based salt structure, and preparation method and application thereof
CN114573616A (en) Ternary electrolyte containing bicyclic salt and preparation method and application thereof
CN114583266A (en) Polycyclic ternary electrolyte and preparation method and application thereof
CN114573619A (en) Ternary oxygen-based electrolyte and preparation and application thereof
CN114230584A (en) Electrolyte containing aromatic ring structure and preparation and application thereof
CN114583267A (en) Boron trifluoride salt ternary electrolyte and preparation and application thereof
CN114573618A (en) Saturated carbon ring ternary electrolyte and preparation and application thereof
CN114573617A (en) Ternary electrolyte containing saturated heterocycles, and preparation and application thereof
CN114573610A (en) Ternary electrolyte containing unsaturated heterocycle and preparation method and application thereof
CN114230588A (en) Binary electrolyte and preparation and application thereof
CN114243105A (en) Electrolyte containing bicyclic salt and preparation and application thereof
CN114649572A (en) Sulfur-based boron trifluoride salt-containing electrolyte and preparation method and application thereof
CN114649576A (en) Electrolyte containing bicyclic sulfur-based salt and preparation method and application thereof
CN114573612A (en) Ternary unsaturated carbocyclic boron trifluoride salt electrolyte and preparation method and application thereof
CN114230589A (en) Boron trifluoride salt electrolyte and preparation and application thereof
CN114605444A (en) Electrolyte containing polycyclic structure and preparation method and application thereof
CN114230590A (en) Boron trifluoride salt electrolyte containing unsaturated heterocycle and preparation and application thereof
CN114685540A (en) Polyoxy boron trifluoride salt electrolyte and preparation method and application thereof
CN114649574A (en) Sulfur-based boron trifluoride salt electrolyte containing unsaturated carbon rings and preparation method and application thereof
CN114649585A (en) Polycyclic sulfur-based electrolyte and preparation method and application thereof
CN114621265A (en) Electrolyte containing saturated heterocyclic structure and preparation method and application thereof
CN114230591A (en) Polycyclic electrolyte and preparation and application thereof
CN114605442A (en) Multi-sulfur-based boron trifluoride salt electrolyte and preparation method and application thereof
CN114573611A (en) Ternary electrolyte containing aromatic ring structure and preparation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20220603